Scholar Rock Holding Corp at JPMorgan Healthcare Conference Transcript
Welcome everyone to the 44th Annual JPMorgan Healthcare Conference. My name is Tessa Romero, and I'm one of the senior biotech analysts here at JPMorgan. We're very pleased to be kicking off the conference with Scholar Rock and presenting on behalf of the company, we have Chairman and CEO, David Hallal.
David, over to you.
Thank you very much, Tess. It's great to be kicking off the JPMorgan Conference early on a Monday morning, and we are super excited for our week here in San Francisco, as well as 2026, which will be a transformative year for the company. I want to thank Tess, JPMorgan, everybody here in the room in California East, as well as many, many others that are tuning in remotely via webcast.
Scholar Rock is in a position of strength as we enter 2026. We are the world leaders in myostatin biology, and with that capability, we are shaping the future of treatment for patients living with rare neuromuscular
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
